PHI Air Medical Equips Air Ambulances with ZOLL Propaq MD
November 18, 2010 -- CHELMSFORD, MASS. -- ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of medical devices and related software solutions, has announced that PHI Air Medical of Phoenix, Arizona, a business unit of PHI, Inc. (Nasdaq GM: PHIIK), is the first major installation for the new ZOLL Propaq® MD Monitor/Defibrillator in North America and will standardize its fleet of air ambulances with the new equipment.
The Propaq MD is an ultra-lightweight compact device with highly sophisticated, advanced capabilities that combine the well-accepted and proven features of Propaq monitors with the clinically superior therapeutic capabilities of ZOLL defibrillation and non-invasive pacing technologies. The Propaq MD is 60 percent smaller and 40 percent lighter than similar monitor/defibrillators. It is two pounds lighter than the current air medical vital signs monitor even with defibrillation and pacing added. Thanks to a joint undertaking between the Department of Defense and a cooperative arrangement between Welch Allyn and ZOLL, it was developed specifically to meet the special needs of air medical operations and military customers worldwide.
"At PHI, we are committed to our patients and crews, to not only identify, but be early adopters of the leading technologies and advances in our industry. We are excited to standardize our entire medical operations with the Propaq MD," said Linda Young, Director of Clinical Standards at PHI Air Medical. "This product will have an immediate positive impact on the care we provide our patients. ZOLL has demonstrated its understanding of our industry and the technological advances required by our professional clinicians and care givers."
"PHI's adoption of the Propaq MD is indicative of the extent to which this civilian air ambulance operator goes through to provide top-level critical care to patients," said Jonathan A. Rennert, President of ZOLL. "Due to its advanced capabilities and compact size, the Propaq MD replaces the need for separate monitors and defibrillators, resulting in more cabin space and reduced weight. With its small footprint, it's also easy to mount inside the aircraft."
The Propaq MD provides an unmatched combination of capabilities that include a large, high-contrast color LCD display capable of showing up to four waveforms simultaneously, as well as a full 12-lead ECG for on-screen review. It also offers a unique night vision goggle (NVG) mode. All physiological monitoring parameter values, including heart rate, SpO2, ETCO2, respiration, non-invasive blood pressure, two temperatures, and three invasive pressures, are shown in large color-coded numeric formats. The device is capable of monitoring all patients, whether adult, pediatric or neonatal. The Propaq MD is the only FDA-cleared airworthy defibrillator to provide monitoring of three invasive pressures necessary for treating critical patients during long transports. The system also incorporates a new battery that will monitor all physiological parameters for over six hours on a single battery charge.
In addition to real-time monitoring, the Propaq MD has a full data collection and trending capability. Keys are provided to annotate all ACLS interventions such as intubation, drug administration, and associated ECG and other physiological waveform segments. Full trending data is available on the unit's display from its integral memory, supporting data collection over 24-hour periods. All data can be downloaded to a standard USB flash drive and transferred to electronic medical records using an open architecture XML format. An integrated printer can provide immediate documentation of events and diagnostic ECG traces.
Designed to withstand the tough demands encompassing air transport, the Propaq MD meets an unprecedented number of international standards related to durability, environmental operation and storage extremes, radio frequency emissions, and susceptibility to spurious electrical and radio frequency noise. The Propaq MD is also rated at the most stringent IP55 rating for dust and water ingress protection.
About PHI Air Medical
PHI Air Medical, Inc. is a business unit of PHI, Inc., the world leader in rotary flight for over 50 years, and provides support for many of the nation's leading health care organizations. PHI Air Medical Pilots have recorded more that 10 million flight hours, in virtually every type of helicopter and terrain known. The Air Medical Group fleet consists of proven aircraft outfitted with medical interiors conducive to providing sustained emergent care for air medical transports and most PHI Air Medical programs operate at or above Commission on Accreditation of Medical Transport Systems (CAMTS) standards.
About ZOLL Medical Corporation
ZOLL Medical Corporation develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.
A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company in 2007, 2008, and 2009, ZOLL develops and manufactures its products in the United States, in California, Colorado, Illinois, Massachusetts, Pennsylvania, and Rhode Island. More than 400 direct sales and service representatives, 1,100 business partners, and 200 independent representatives serve our customers in over 140 countries around the globe.
For more information, visit www.zoll.com.